G
The Government's requirements are:
1) The contractor will assemble a study team that includes researchers with necessary clinical and statistical expertise to analyze data from the NHCR to: (1)Explore issues related to bowel preparation quality: (a)Examine variation in the percentage of exams with fair/poor preparation by endoscopist and endoscopy center. The percentage of exams with poor or fair preparations will be examined. In addition, adenoma detection rates will be calculated for surveillance and screening exams separately. Serrated polyp detection rates will also be examined. (b) Determine patient and endoscopist/practice characteristics associated with fair/poor preparation. Patient and endoscopy characteristics will be examined to determine factors predictive of inadequate preparation. In addition, factors that are unique to each center will be examined. Methods of preparation such as split dose preparation as well as the type of instructions given to patients will be included in this analysis. (c) Examine the association between limited preparation quality and findings at colonoscopy, based on the findings at the baseline and subsequent exam. This analysis will provide evidence for establishing screening and surveillance guidelines for patients with suboptimal preparation quality. Longitudinal data will be examined from screening and surveillance colonoscopies performed in patients with baseline and subsequent colonoscopies in the NHCR. Using patient data such as demographic and lifestyle information, and quality data, the quality of preparation as a predictive factor for detection of advanced neoplasia will be examined.
2) Provide evidence for judging the appropriateness of existing surveillance guidelines by examining the association between findings at the first colonoscopy exam and findings at the second colonoscopy exam. Patients will be classified into high and low risk categories, based on findings at baseline and follow-up. For example, it is anticipated that a patient with 3 diminutive adenomas may have a lower risk for advanced neoplasia on surveillance than a patient with 3 adenomas, one of which is small or large. This issue has been highlighted within the MSTF recent guidelines, and has a potentially highly significant impact on patient risk and health-care costs.
The Government intends to solicit, negotiate and award to only one contractor using Simplified Acquisition Procedures pursuant to FAR Subpart 13.1. A determination not to compete this requirement is based on market research and is solely within the discretion of the Government. This announcement is not a request for competitive quotations. All interested responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the CDC to David Kelley by email at [email protected].
No solicitation is available and telephone requests for information will not be honored. This notice of intent is not a request for competitive proposals; however, the Government shall consider all responses received within five (5) days of this posting. A determination by the CDC not to compete this proposed contract, based upon responses to this notification, is solely within the discretion of the government.
CLIN 0001: Improving Colonoscopy
Anticipated Period of Performance: 09/16/2013 - 09/15/2014
NAICS Code: 541690 - Other Scientific and Technical Consulting Services
Estimated Award Amount: $100,382.00
Proposed Contract No.: 200-2013-F-57405
The Vendor is not a Small Business
Centers for Disease Control and Prevention (PGO)
Procurement and Grants Office
2920 Brandywine Rd, RM 3000
Atlanta, GA 30341-5539